Should DCIS be renamed carcinoma of the ductal system?

Breast Journal

Volumn 5, Issue 1, 1999, Pages 70-72

  Barsky, Sanford H ^a,b   Shao, Zhi Ming ^a   Bose, Shikha ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CARCINOMA; CANCER CELL; CANCER CLASSIFICATION; CANCER GENETICS; CANCER INVASION; CELL CYCLE; HUMAN; HUMAN CELL; REVIEW;

EID: 0032975251     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4741.1999.005001070.x     Document Type: Review

References (20)

1. Silverstein MJ. Ductal carcinoma in situ of the breast. Baltimore: Williams & Wilkins, 1997.
2. Busque L, Zhu J, Dehart D, et al. An expression based clonality assay at the human androgen receptor locus (HUMARA) on chromosome X. Nucleic Acids Res 1994;22:697-98.
3. Gilliland DG, Blanchard KL, Levy J, Perrin S, Bunn HF. Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction. Proc Natl Acad Sci USA 1991; 88:6848-52.
4. Sternlicht M, Mirell C, Safarians S, Barsky SH. A novel strategy for the investigation of clonality in precancerous disease states and early stages of tumor progression. Biochem Biophys Res Commun 1994;199:511-18.
5. Noguchi S, Motomura K, Inaji H, Imaoka S, Koyama H. Clonal analysis of predominately intraductal carcinoma and precancerous lesions of the breast by means of polymerase chain reaction. Cancer Res 1994;54:1849-53.
6. de Vijver M, Peterse J, Mooi W, et al. Neu-protein overexpression in breast cancer. N Engl J Med 1988;319: 1239-45.
7. Meyer JS. Cell kinetics of histologic variants of in situ breast carcinoma. Breast Cancer Res Treat 1986;7:171-80.
8. Zhuang Z, Merino MJ, Chuaqui R, Liotta LA, Emmert-Buck MR. Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer. Cancer Res 1995;55:467-71.
9. James LA, Mitchell EL, Menasce L, Varley JM. Comparative genomic hybridisation of ductal carcinoma in situ of the breast: identification of regions of DNA amplification and deletion in common with invasive breast carcinoma. Oncogene 1997;14:1059-65.
10. Chen T, Sahin A, Aldaz CM. Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor gene region. Cancer Res 1996;56:5605-9.
11. Bose S, Wang SI, Terry MB, Hibshoosh H, Parsons R. Allelic loss of chromosome 10q23 is associated with tumor progression in breast carcinomas. Oncogene 1998;17:123-27.
12. Kuukasjarvi T, Tanner M, Pennanen S, Karhu R, Kallioniemi OP, Isola J. Genetic changes in intraductal breast cancer detected by comparative genomic hybridization. Am J Pathol 1997;150:1465-71.
13. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84: 1875-87.
14. Sternlicht MD, Barsky SH. The myoepithelial defense: a host defense against cancer. Med Hypotheses 1997;48:37-46.
15. Sternlicht MD, Safarians S, Calcaterra TC, Barsky SH. Establishment and characterization of a novel human myoepithelial cell line and matrix-producing xenograft from a parotid basal cell adenocarcinoma. In Vitro Cell Dev Biol 1996;32: 550-63.
16. Sternlicht MD, Safarians S, Rivera SP, Barsky SH. Characterizations of the extracellular matrix and proteinase inhibitor content of human myoepithelial tumors. Lab Invest 1996; 74:781-96.
17. Sternlicht MD, Kedeshian P, Shao ZM, Safarians S, Barsky SH. The human myoepithelial cell is a natural tumor suppressor. Clin Cancer Res 1997;3:1949-58.
18. 2/M arrest and apoptosis. Exp Cell Res 1998;241:394-403.
19. Bodis S, Siziopikou KP, Schnitt SJ, Harris JR, Fisher DE. Extensive apoptosis in ductal carcinoma in situ of the breast. Cancer 1996;77:1831-35.
20. Shao ZM, Barsky SH. The anti-invasive phenotype of breast myoepithelial cells is hormonally regulated. 3rd Annual Multidisciplinary Symposium on Breast Disease, Amelia Island, Florida 1998.